The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Inland Homes snaps up 50% stake in Cheshunt Lakeside Development

Tue, 29th Oct 2019 15:30

(Sharecast News) - Inland Homes on Tuesday acquired a 50% interest in joint-venture partner Cheshunt Lakeside Developments Limited that was held by CPC Group Limited.
The brownfield developer, housebuilder and partnership housing company also confirmed it had transferred a 50% equity interest in the acquisition to a new joint-venture partner for a consideration of £28.5m in cash payable on deferred terms, maintaining the off balance sheet nature of the project.

The AIM traded company said a planning application for reserved matters in respect of 195 initial homes at the Cheshunt site will be submitted shortly, with building set to commence in early 2020.

In the meantime, preparations for the development had begun, including the demolition of some buildings.

The target of the development was to create an "urban village" comprising 1,725 homes, 19,000 square metres of commercial space and provision for a new primary school.

Chief executive Stephen Wicks said: "Having secured the planning consent at Cheshunt Lakeside, we have now achieved another important step forward on this site by acquiring our original joint venture partner. We welcome our new partner with whom we have entered into a beneficial arrangement that will enable Inland to receive the majority of the development profits from this site."

Inland Homes shares were up by 2.50% at 78.62p at 1545 GMT.
More News
12 Jan 2015 11:55

Verona Pharma doses first volunteers in 'RPL554' asthma trial

Verona Pharma said the first group of volunteers have been dosed with its new nebulised formulation of its RPL554 product as part of a Phase I/II clinical trial, which analysts said was a significant step. The AIM company said the study's main objective was to confirm the safety, tolerability and br

Read more
12 Jan 2015 09:23

Verona Pharma Doses First Recruitments In RPL554 Clinical Trial

Read more
30 Sep 2014 12:38

CORRECT: UK WINNERS & LOSERS: Intertek's Gain Is Inchcape's Loss On CEO Change

Read more
30 Sep 2014 12:35

UK MIDDAY BRIEFING: Clothing Retailers Hit By Next Weather Warning

Read more
30 Sep 2014 11:51

UK WINNERS & LOSERS: Intertek's Gain Is Inchcape's Loss On CEO Change

Read more
30 Sep 2014 09:07

Verona Pharma Appoints Biresh Roy As Chief Financial Officer

Read more
29 Sep 2014 07:45

Verona Shares Up As Data Shows Potential Of RPL554 In Cystic Fibrosis

Read more
11 Sep 2014 11:01

Verona Pharma Posts Widened Loss As It Continues Drug Development

Read more
23 Jun 2014 10:47

UK MIDDAY BRIEFING: ASOS Hit By Suspicious Warehouse Fire

Read more
23 Jun 2014 10:10

UK WINNERS & LOSERS: Mining Companies Cheered By China PMI Data

Read more
23 Jun 2014 07:27

UK MORNING BRIEFING: Shares Down As Iraq Fighting Lifts Oil Prices

Read more
23 Jun 2014 06:47

Verona Pharma To Halt VRP700 Development After Trial Failure

Read more
28 Apr 2014 08:53

Verona Pharma Loss Widens As It Continues To Develop Pipeline Drugs

LONDON (Alliance News) - Verona Pharma PLC Monday posted a widened pretax loss for 2013 as it continued to develop its two pipeline drugs towards commercialisation. Veron posted a pretax loss of GBP2.8 million, widened from a pretax loss of GBP2.6 million in 2012, as administration expense

Read more
7 Mar 2014 12:51

UK MIDDAY BRIEFING: Boohoo.com Latest On IPO Catwalk

LONDON (Alliance News) - Online fashion retailer Boohoo.com, the latest UK retailer to firm up its initial public offering, has said it plans to raise GBP300 million in the AIM listing, giving it a higher-then-expected initial market capitalisation of GBP560 million.

Read more

7 Mar 2014 10:57

UK WINNERS & LOSERS: Aviva Leads Blue-Chip Risers Again

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Aviva, up 4.2%. After closing as the blue-chip index's biggest riser on Thursday, Aviva is again the stand out performer Frid

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.